Loading...
XIDX
SILO
Market cap1.76bUSD
Nov 12, Last price  
2,420.00IDR
Name

Siloam International Hospitals Tbk PT

Chart & performance

D1W1MN
XIDX:SILO chart
P/E
28.25
P/S
2.45
EPS
85.67
Div yield, %
0.83%
Shrs. gr., 5y
-0.01%
Rev. gr., 5y
12.56%
Revenues
12.85t
+5.24%
1,030,471,740,4811,259,348,565,5581,788,082,522,1632,503,599,992,9163,340,793,371,8734,144,118,302,5855,168,363,067,2775,848,006,000,0005,964,650,000,0007,017,919,000,0007,110,124,000,0009,381,891,000,0009,518,012,000,00011,190,511,000,00012,207,563,000,00012,847,434,000,000
Net income
1.11t
+23.33%
67,476,614,02543,740,346,32050,461,221,66249,870,418,85562,568,928,88170,396,404,16085,900,715,38293,566,000,00016,182,000,000-332,998,000,000116,163,000,000674,117,000,000696,495,000,0001,211,283,000,000902,152,000,0001,112,663,000,000
CFO
2.46t
+5.67%
263,397,573,77153,425,042,813203,007,300,458189,449,895,676283,680,074,153255,145,682,013239,865,949,631225,781,000,000203,640,000,000651,507,000,0001,336,602,000,0002,033,133,000,0001,495,001,000,0002,098,469,000,0002,330,197,000,0002,462,333,000,000
Dividend
Jun 10, 202420 IDR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

PT Siloam International Hospitals Tbk operates hospitals and clinics in Indonesia. The company offers general, pre-marital, and lite checkups; male and female screenings; heart, kidney, and cancer screenings; visa application and preemployment screenings; and vaccine and genomic testing services. It also provides diagnostic services, including laboratory and radiology checks; home services; COVID-19 tests; radiation therapy; and teleconsultation services. In addition, it offers services in the areas of andrology, anesthesiology, and arrythmia; cardiothoracic, digestive, general, neuro, pediatric, plastic, and vascular surgery; cardiology, cardiovascular emergency and intensive care, cardiovascular imaging, pediatric cardiology and congenital heart diseases, and preventive cardiology and cardiac rehabilitation; clinical nutrition and psychology; medical acupuncture and laboratory; dermatology, venereology, and aesthetics; and echocardiography, internal medicine, interventional cardiology, neurology, nuclear medicine, obstetrics and gynecologist, occupational medicine, ophthalmology, orthopedic and traumatology, otorhinolaryngology, physical medicine and rehabilitation, pulmonology, radiation oncology, radiology, sports medicine, and urology. Further, it engages in trading, development, mining, agriculture, land transportation, printing, plantation, forestry, electrical, mechanical, engineering, construction, and real estate businesses; computer programming; software publishing and retail trading; provision of management consulting, retail, professional, and scientific and technical; web portal and/or digital platform business; workshops; leasing; wholesale trade; IT; and social services. The company was formerly known as PT Sentralindo Wirasta. PT Siloam International Hospitals Tbk was founded in 1996 and is headquartered in Tangerang, Indonesia. PT Siloam International Hospitals Tbk operates as a subsidiary of Sight Investment Company Pte. Limited.

Key people

President Commissioner · since 2017
President Director · since 2017
Caroline Riady
Vice President Director · since 2016
Atiff Ibrahim Gill
Director · since 2016
Grace Frelita Indradjaja
Director · since 2007
Marta Jonatan
Independent Director · since 2017
Meng Kuan Phua
Director · since 2019
Anang Prayudi
Director · since 2014
Monica Surjapranata
Director · since 2019
Ryanto Marino Tedjomulja
Director · since 2017
Indra Lesmana Hertanto
Corporate Secretary · since 2017
John Nicholas Pitsonis
Commissioner · since 2016
Commissioner · since 2016
Independent Commissioner · since 2019
IPO date
Sep 12, 2013
Employees
Domiciled in
ID
Incorporated in
ID
Legal address
Gedung Fakultas Kedokteran UPH Lt. 32, Jl. Boulevard Jend.Sudirman No.15
Tangerang, JW 15810
ID
Headquarters
Fakultas Kedokteran Universitas Pelita Harapan – Lantai 32, Jalan Boulevard Sudirman No. 1688, Lippo Village
Tangerang, JW 15811
ID

Valuation

Title
IDR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT